News

Eli Lilly Stock Gets a Double Downgrade. Where Weight-Loss Drugs Go From Here.
The lower rating came from HSBC, which cited too much optimism around its new weight-loss pill, and the strength of Novo ...
Is Eli Lilly Stock a Portfolio Must-Have Pre-Q1 Earnings? (Revised)
Eli Lilly and Company LLY will report its first-quarter earnings on May 1, before market open. The Zacks Consensus Estimate for sales and earnings is pegged at $12.62 billion and $3.52 per share, ...
Stocktwits on MSN4h
Eli Lilly Stock Gets A Double Downgrade And Price Target Cut By HSBC Over Valuation, Competition Concerns
HSBC on Monday double downgraded Eli Lilly and Co. (LLY) stock to ‘Reduce’ from ‘Buy’ and also lowered its price target to ...
Weight-loss craze sparks a DC lobbying bonanza
President Donald Trump is under pressure to decide how widely available anti-obesity drugs should be and whether Medicare ...
ISRG, LLY, or DXCM: Which “Strong Buy” Healthcare Stock Has the Highest Upside Potential?
Tariff wars and macro woes have impacted investor sentiment, weighing on stocks across various sectors. However, healthcare ...